(Q61827013)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Impact of high-dose chemotherapy followed by auto-SCT for positive interim [18F] FDG-PET diffuse large B-cell lymphoma patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

1 reference

diffuse large B-cell lymphoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Françoise Kraeber-Bodéré

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

V Roland

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

A Moreau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

T Gastinne

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

B Mahé

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

V Dubruille

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

H Maisonneuve

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

N Juge-Morineau

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

P Moreau

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

H Jardel

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

L Planche

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

M Mohty

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

P Moreau

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

J-L Harousseau

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

S Le Gouill

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

English

0 references

publication date

31 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

393-399

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20577223%20AND%20SRC:MED&resulttype=core&format=json

Revised response criteria for malignant lymphoma

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

Prognostic value of early 18 fluorodeoxyglucose positron emission tomography and gallium-67 scintigraphy in aggressive lymphoma: a prospective comparative study.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

Early therapeutic response assessment by (18)FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

The impact of pre- and post-transplantation positron emission tomography using 18-fluorodeoxyglucose on poor-prognosis lymphoma patients undergoing autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.130

7 January 2021